The Moderna COVID-19 vaccine has become the second jab to ... COVID-19 vaccines and this surveillance will include the 12 to 17 year age group," she added. The MHRA approval came through the ...

Both Moderna and Pfizer began testing their Covid-19 vaccines on children aged 12 years and older last year. Results on these trials are pending. AstraZeneca announced its first trial on children ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

The pharmaceutical company Moderna today announced the provisional ... FDA with additional follow-up data on its vaccine for children aged 12 to 17 years. Children that age would receive two ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna ...

At 13 years ... vaccine. The Food and Drug Administration hasn't approved the shots for kids under 16 due to a lack of data. But the Preston brothers are participants in Moderna's clinical trial ...

Despite giving the world one of the first and most widely used COVID-19 vaccines, shares of Moderna ... On Sept. 12, management issued fresh sales guidance for the full year 2025 and also revised ...

from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later, the agency authorized an updated version of Novavax’s protein subunit vaccine for people 12 years and older.